R.PR
REGISTERED-PRINCIPAL REGISTER
03/04/2025
Back to search
Official data from USPTO
ANDELYN BIOSCIENCES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
14
Latest update
03/04/2025
Trademark type
Combined
Nice classes
40, 42
Filing date
06/05/2024
Registration date
03/04/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/04/2025
Last transaction
03/04/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/09/2024
First use in commerce
05/09/2024
Drawing code
3
Owner type
03
Owner location
Columbus, OH
Examiner
PHILLIPS, WENDELL SHARMAN
Law office
M10
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the words ANDELYN BIOSCIENCES with four hexagons to the right of the word BIOSCIENCES.
Holders and representatives
Holders
Andelyn Biosciences, Inc.
Representatives
Ajay A. Jagtiani Miles & Stockbridge P.C.
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Manufacturing services for others in the field of pharmaceuticalsbiopharmaceuticalshealth care products and medical products; treatment of materialspharmaceutical and chemical products and their components used in the manufacture of pharmaceuticals and biopharmaceuticals; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticalscells and gene therapy reagents.
Class 42
Product development for others relating to pharmaceuticalsbiopharmaceuticalshealth care products and medical products; scientific and technological consulting services in the pharmaceutical industryresearch and design relating thereto; industrial analysis in the nature of product testing and research and industrial research in the field of pharmaceuticalsbiopharmaceuticalshealth care products and medical products; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; product development consultation; product research servicesproviding analytical testingbiosafety testingreporting and laboratory services for others; scientific and technical product development consulting and research services for the pharmaceutical industry; custom design and development of chemical reagents and biochemical assays.
Publications
History of USPTO decisions and trademark events.
14 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/14/2025
PUBO
PUBLISHED FOR OPPOSITION
01/14/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/08/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/20/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
12/20/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/20/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
12/20/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/20/2024
DOCK
ASSIGNED TO EXAMINER
12/18/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/17/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/17/2024
NWAP
NEW APPLICATION ENTERED
06/05/2024
Continuous trademark protection
Get notified about every new filing that threatens ANDELYN BIOSCIENCES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.